skip-to-main

Spikevax XBB.1.5

0.1 mg/mL formulation

Spikevax XBB.1.5 is indicated for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 months of age and older.

xbb.1.5 carton

Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Tools

Temperature Excursion Tool

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Report Adverse Events

Report Adverse Events

You can report any adverse events to Moderna via the Adverse Event Intake Portal or by calling 1-800-622-4937.

Contact Moderna

    © 2023 Moderna, Inc.

    SG-COV-2100003 11/2023